NT5E Antibody

1. Changes in the local expression and activity of CD39 and CD73 in calcified valves suggest their potential role in calcific aortic valve disease. PMID:30056298
2. High expression of NT5E is associated with Prostate Cancer. PMID:29916747
3. Case Report: identify novel mutations in the NT5E gene in patient with calcification of joints and arteries. PMID:28825389
4. High CD73 expression is associated with breast cancer. PMID:29047106
5. High CD73 expression is associated with neoplasms. PMID:29514610
6. NT5E-targeting miRNAs (miR-30b and miR-340) function as tumor suppressors PMID:29155108
7. soluble CD73 might be used as serologic prognostic biomarker in patients with metastatic melanoma patients. PMID:29202855
8. High CD73 expression is associated with the increase in the ability of surviving breast cancer cells to evade innate and adaptive immunity. PMID:29367423
9. analysis of how inhibitors block human CD73 and block efficiently its enzymatic function in the low micromolar range through a non-competitive inhibition mechanism PMID:29377887
10. The Ecto-5'nucleotidase, together with alkaline phosphatase, also expressed apically in oviductal epithelium, complete the hydrolysis sequence by dephosphorylating AMP to adenosine. PMID:29273916
11. this paper shows that simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro PMID:28389406
12. high levels of CD73 are significantly associated with reduced overall survival in patients with head and neck squamous cell carcinoma PMID:27557512
13. Studied role of miR-30a in colorectal cancer(CRC). Found miR-30a is downregulated in CRC, and it inhibits cell proliferation in CRC by reducing expression of CD73. PMID:28464916
14. we demonstrated the existence of CSCs in both cultured ccRCC cell line and tissues, and CD73 as a cell-surface biomarker for ccRCC CSC-like cells. PMID:28404888
15. Induction of ecto-5'-nucleotidase/CD73 by radiation contributes to the radiosensitivity of T24 urinary bladder cancer cell line. PMID:29305710
16. Report prognostic impact of CD73 expression in non-small lung cancers. PMID:28060732
17. Data show that MiR-422a and its target CD73 are involved in early loco(regional) recurrence of head and neck squamous cell carcinoma (HNSCC) tumors and are targets for personalized medicine. PMID:27281619
18. HPV+ cervical cancer cells express higher levels of CD73 than HPV- cells, and this expression is associated with the production of larger amounts of adenosine, as well as a stronger inhibition of proliferation, activation, and cytotoxic activity of CD8+ T cells via interaction with A2A adenosine receptor PMID:28950987
19. High CD73 expression is associated with Melanoma Metastasis. PMID:28652244
20. Hippocampal astrogliosis observed in medial temporal lobe epilepsy patients was accompanied by a proportionate increase in A2A receptor and ecto-5'-nucleotidase/CD73 immunoreactivities. PMID:27650530
21. High CD73 expression is associated with cervical cancer. PMID:28202050
22. Endogenous Plastic Somatic (ePS) cells in a latent state, i.e. lacking SOX2, OCT3/4 and NANOG (SON) expression, in non-diseased breast specimens through immunohistochemical analysis of previously identified ePS-specific biomarkers (CD73(+), EpCAM(+) and CD90(-)). PMID:27705752
23. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. PMID:28193736
24. CD73 polymorphisms play a role in calciphylaxis development in dialysis patients. PMID:28212442
25. CD73 expression is upregulated in NSCLC and is correlated with a decrease in miR-30a-5p expression. PMID:28158983
26. This study found that in septic critically ill patients the soluble CD73 levels were generally low and showed a further decrease from 0h to 24h. Moreover, the sCD73 levels were higher in acute kidney injury (AKI) versus non-AKI patients and in non-survivors with severe sepsis than in survivors, but were not independently associated either with the development of AKI or 90-day mortal PMID:27732656
27. concluded that CD39 and CD73 are molecular targets for the development of drugs for ALF patients care PMID:27899277
28. Genetic polymorphism of NT5E may contribute to the pathogenesis of calcific aortic valve disease. PMID:27906615
29. Oxidized low density lipoproteins modulate CD39 and CD73 activity in the endothelium. PMID:27906627
30. CD73 may play an important role in breast cancer stem cells. PMID:27670764
31. This study aimed to investigate the activities of purinergic system ecto-enzymes present on the platelet surface as well as CD39 and CD73 expressions on platelets of sickle cell anemia treated patients. PMID:27044834
32. Aim of the present study was to investigate the role of CD73 in glioma blood vessels; results found that the expression of CD73 in glioma vascular cells is significantly decreased, and this reduction may down-regulate the expression of brain microvascular endothelial tight junction-related proteins PMID:26884147
33. These results provide a finely mapped epitope that can be targeted for selective, potent, and non-competitive inhibition of CD73, as well as establish a strategy for inhibiting enzymes that function in both membrane-bound and soluble states. PMID:26854859
34. CD73 promotes the growth of human colorectal cancer cells through EGFR and the b-catenin/cyclin D1 signaling pathway. CD73 may be used as a valuable biomarker of colorectal cancer. PMID:26708311
35. Our study revealed that CD73 is an independent prognostic factor in prostate cancer. PMID:26253870
36. The NT5E gene is involved in both intrinsic and acquired resistance to platinum-based drugs in ovarian cancer. [meta-analysis] PMID:26629888
37. CD73 expression was significantly correlated with the invasion into adjacent organs. PMID:26691441
38. report on a Chinese family with CALJA and novel compound heterozygous mutations (c.1360G>A (p.Gly454Arg) and c.1387C>T (p.Arg463X)) in NT5E PMID:26178434
39. findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression PMID:26642367
40. CD73 activity from any host cell type is not required for the monocyte/macrophage polarization in the peritoneum towards a pro- or an anti-inflammatory phenotype in vivo PMID:26258883
41. these data suggest a possible role for CD73 and A2A in inflammation observed in patients with T2D and obesity mediated via apoptosis. PMID:25770019
42. This study highlights a role for CD73 as a prognostic marker of patient survival and also as a candidate therapeutic target in high-grade serous ovarian cancers. PMID:26363007
43. role of CD73 and CD39 ectonucleotidases in T cell differentiation PMID:26226423
44. Expression of NPP1 and 5'-nucleotidase by valve interstitial cells promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB pathway. PMID:25644539
45. Although upregulated CD73 expression in tumor cells correlates with a poor prognosis in patients with rectal adenocarcinoma, the combination of CD73 expression in malignant epithelial cells and tumor stroma may have a better prognostic value PMID:25677906
46. rs9444348 heterozygosity is associated with increased risk of post-traumatic epilepsy development after brain injury. PMID:26040919
47. Species-specific CD73 regulation, with potential significance to cancer, fibrosis, and other diseases characterized by changes in CD73 expression and function. PMID:25298403
48. The Nt5e(-/-) targeted mutant mice recapitulate some, but not all, features of ACDC and serve as a model system to study pharmacologic interventions for ectopic mineralization. PMID:25486201
49. CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature. PMID:25402681
50. It decompose ATP and produce adenosine, which regulates immunity via adenosine receptor. PMID:25675814

Show More

Hide All

HGNC: 8021

UNIGENE: Hs.153952

KEGG: hsa:4907

STRING: 9606.ENSP00000257770

OMIM: 129190